[1]
“CAR T-Cell Immunotherapy in Large B-Cell Lymphoma: Viral Etiology, Stem Cell Engineering, and AI/ML-Guided Gene Therapy for Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)”, CRDPPS, pp. 97–115, Aug. 2026, Accessed: Aug. 27, 2026. [Online]. Available: https://crdpps.nknpub.com/1/article/view/34